{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:28:22Z","timestamp":1792301302199,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011644.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:00:00Z","timestamp":1543795200000}}],"reference-count":109,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011644.pub3","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T21:48:06Z","timestamp":1544132886000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological interventions for acute hepatitis C infection"],"prefix":"10.1002","volume":"2018","author":[{"given":"Maria","family":"Kalafateli","sequence":"first","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Buzzetti","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"Royal Free Campus, UCL Medical School; Department of Surgery; Pond Street London UK NW3 2QG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurinchi Selvan","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; 9th Floor, Royal Free Hospital Rowland Hill Street London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0001|cit1","first-page":"181","article-title":"Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial","volume":"30","author":"Calleri","year":"1998","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"issue":"2B","key":"10.1002\/14651858.CD011644.pub3-BIB0002|cit2","first-page":"1279","article-title":"Preliminary report of a controlled trial of MTH-68\/B virus vaccine treatment in acute B and C hepatitis: a phase II study","volume":"18","author":"Csatary","year":"1998","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1473-3099(13)70059-8","article-title":"Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial","volume":"13","author":"Deterding","year":"2013","journal-title":"Lancet Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0005|cit4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/0016-5085(92)91205-I","article-title":"Interferon alfa in acute posttransfusion hepatitis C: a randomized, controlled trial","volume":"103","author":"Genesca","year":"1992","journal-title":"Gastroenterology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011644.pub3-BIB0004|cit5","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1136\/gut.34.2_Suppl.S62","article-title":"Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b","volume":"34","author":"Genesca","year":"1993","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0168-8278(94)80246-7","article-title":"A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C","volume":"21","author":"Hwang","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1111\/j.1440-1746.1993.tb01691.x","article-title":"A randomized controlled clinical trial of recombinant interferon alpha-2b in the treatment of acute post-transfusion hepatitis C: a preliminary report","volume":"8","author":"Hwang","year":"1993","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.1840190105","article-title":"A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C","volume":"19","author":"Lampertico","year":"1994","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0009|cit9","first-page":"111","article-title":"Treatment of acute post-transfusional non-a, non-b hepatitis with recombinant interferon alpha-2b. A multicenter randomized controlled trial","volume":"7","author":"Lampertico","year":"1994","journal-title":"Argomenti Gastroenterologia Clinica"},{"issue":"8772","key":"10.1002\/14651858.CD011644.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0140-6736(91)91774-O","article-title":"Resolution of acute hepatitis C after therapy with natural beta interferon","volume":"338","author":"Omata","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-4-431-68255-4_156","article-title":"A randomized, controlled trial of interferon-beta treatment for acute hepatitis C","volume-title":"Proceedings of the international symposium on viral hepatitis and liver Disease","author":"Omata","year":"1994"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/hep.26991","article-title":"Acute hepatitis C: a 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin","volume":"59","author":"Santantonio","year":"2014","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD011644.pub3-BIB0013|cit13","first-page":"673a","article-title":"Randomized trial of pegylated interferon for the treatment of acute HCV in Seattle injection drug users","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0014|cit14","unstructured":"American Association for the Study of Liver Diseases Infectious Diseases Society of America Recommendations for testing, managing, and treating hepatitis C, 2014 www.hcvguidelines.org\/fullreport"},{"issue":"6265","key":"10.1002\/14651858.CD011644.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.282.6265.674-a","article-title":"Interferon production by genetic engineering","volume":"282","author":"Anonymous","year":"1981","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/bc000082g","article-title":"Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C","volume":"12","author":"Bailon","year":"2001","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2011.09.039","article-title":"Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection","volume":"142","author":"Beinhardt","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/CMR.13.3.385","article-title":"Risk and management of blood-borne infections in health care workers","volume":"13","author":"Beltrami","year":"2000","journal-title":"Clinical Microbiology Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MCG.0000000000000076","article-title":"Distinct features in natural history and outcomes of acute hepatitis C","volume":"40","author":"Bunchorntavakul","year":"2015","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD011644.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation, a multicenter experience","volume":"60","author":"Coilly","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e63509","DOI":"10.1371\/journal.pone.0063509","article-title":"Efficacy of new generation antidepressants: differences seem illusory","volume":"8","author":"Re","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"Demets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7-8","key":"10.1002\/14651858.CD011644.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0029|cit29","unstructured":"Dias S Sutton AJ Welton NJ Ades AE NICE DSU Technical Support Document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment, September 2011 (last updated April 2012) www.nicedsu.org.uk\/TSD3%20Heterogeneity.final%20report.08.05.12.pdf"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0030|cit30","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU Technical Support Document 1: introduction to evidence synthesis for decision making, April 2011 (last updated April 2012) www.nicedsu.org.uk\/TSD1%20Introduction.final.08.05.12.pdf"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0031|cit31","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU Technical Support Document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, August 2011 (last updated April 2014) www.nicedsu.org.uk\/TSD2%20General%20meta%20analysis%20corrected%2015April2014.pdf"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0032|cit32","unstructured":"Dias S Welton NJ Sutton AJ Caldwell DM Lu G Ades AE NICE DSU Technical Support Document 4: inconsistency in networks of evidence based on randomised controlled trials, May 2011 (last updated April 2014) www.nicedsu.org.uk\/TSD4%20Inconsistency.final.15April2014.pdf"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"60","author":"European Association for Study of Liver","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD011644.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3111\/13696998.2012.681332","article-title":"Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas","volume":"15","author":"Khoury","year":"2012","journal-title":"Journal of Medical Economics"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0036|cit36","unstructured":"EuroQol About EQ-5D, 2014 www.euroqol.org\/about-eq-5d.html"},{"issue":"7053","key":"10.1002\/14651858.CD011644.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cit799","article-title":"Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men","volume":"58","author":"Fierer","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jhep.2013.03.020","article-title":"Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C","volume":"59","author":"Furusyo","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0091270003258669","article-title":"Global burden of disease (GBD) for hepatitis C","volume":"44","author":"Global Burden of Hepatitis C Working Group","year":"2004","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Gluud C Koretz R Gurusamy K Hepatitis C: a new direction, but an old story? Lancet (London, England) 2014 2122 3","DOI":"10.1016\/S0140-6736(14)61025-4"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0042|cit42","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2015, Issue 1. Art. No.: LIVER"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrgastro.2011.32","article-title":"Treatment of acute HCV infection","volume":"8","author":"Grebely","year":"2011","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","article-title":"Case definitions for acute hepatitis C virus infection: a systematic review","volume":"57","author":"Hajarizadeh","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","article-title":"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890","volume":"59","author":"Hezode","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0048|cit48","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0050|cit50","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"11","key":"10.1002\/14651858.CD011644.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1016\/j.ijid.2010.03.019","article-title":"Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis","volume":"14","author":"Jafari","year":"2010","journal-title":"International Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1572-0241.2008.01825.x","article-title":"Acute hepatitis C: a systematic review","volume":"103","author":"Kamal","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD011644.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011644.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011644.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1537-2995.2009.02322.x","article-title":"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0057|cit57","first-page":"g7809","article-title":"Is widespread screening for hepatitis C justified?","volume":"350","author":"Koretz","year":"2015","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clinical Microbiology and Infection"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jmv.20103","article-title":"High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection","volume":"73","author":"Lehmann","year":"2004","journal-title":"Journal of Medical Virology"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bpg.2012.09.008","article-title":"Second generation direct antivirals and the way to interferon-free regimens in chronic HCV","volume":"26","author":"Lewis","year":"2012","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2036.2010.04549.x","article-title":"The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes","volume":"33","author":"Loomba","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"474","key":"10.1002\/14651858.CD011644.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"9635","key":"10.1002\/14651858.CD011644.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C","volume":"372","author":"Maheshwari","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0066|cit66","unstructured":"Sweetman S editor Martindale: the complete drug reference (online version), 37th edition, 2011 www.pharmpress.com\/product\/MC_MART\/martindale-the-complete-drug-reference"},{"issue":"12","key":"10.1002\/14651858.CD011644.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"issue":"9128","key":"10.1002\/14651858.CD011644.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000369","article-title":"Interferon for acute hepatitis C","author":"Myers","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0070|cit70","unstructured":"NCBI Hepatitis C, 2014 www.ncbi.nlm.nih.gov\/mesh\/68006526"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0071|cit71","unstructured":"NCBI Interferons, 2014 www.ncbi.nlm.nih.gov\/mesh\/68007372"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/21.5.837","article-title":"Intention-to-treat analysis: implications for quantitative and qualitative research","volume":"21","author":"Newell","year":"1992","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0073|cit73","unstructured":"Members of OpenBUGS Project Management Group OpenBUGS 2014"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2165\/11208370-000000000-00000","article-title":"Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C","volume":"72","author":"Perry","year":"2012","journal-title":"Drugs"},{"issue":"21","key":"10.1002\/14651858.CD011644.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"9055","key":"10.1002\/14651858.CD011644.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0077|cit77","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0078|cit78","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/jhep.2000.9714","article-title":"Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975","volume":"32","author":"Rodger","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"issue":"35","key":"10.1002\/14651858.CD011644.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD011644.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/jhep.2001.21905","article-title":"Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study","volume":"33","author":"Seeff","year":"2001","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011644.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1478-3231.2008.01927.x","article-title":"The history of the \"natural history\" of hepatitis C (1968-2009)","volume":"29","author":"Seeff","year":"2009","journal-title":"Liver International"},{"issue":"2","key":"10.1002\/14651858.CD011644.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2517-6161.1993.tb01921.x","article-title":"Bayesian interval estimates which are also confidence intervals","volume":"55","author":"Severini","year":"1993","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"issue":"8","key":"10.1002\/14651858.CD011644.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MCG.0b013e318294148d","article-title":"Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis","volume":"47","author":"Singal","year":"2013","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0093|cit93","unstructured":"StataCorp LP Stata\/SE 14.2 for Windows[64-bit x86-64] 2017"},{"issue":"5","key":"10.1002\/14651858.CD011644.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/00365540510032105","article-title":"Mother to child transmission of hepatitis C virus: rate of infection and risk factors","volume":"37","author":"Syriopoulou","year":"2005","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0095|cit95","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2046-4053-1-41","article-title":"Sample size and power considerations in network meta-analysis","volume":"1","author":"Thorlund","year":"2012","journal-title":"Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.23808","article-title":"Is sexual contact a major mode of hepatitis C virus transmission?","volume":"52","author":"Tohme","year":"2010","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0098|cit98","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2011.03899.x","article-title":"Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN\/UNOS data","volume":"12","author":"Uemura","year":"2012","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"Valkenhoef","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011644.pub3-BIB0102|cit102","unstructured":"Ware JE SF-36\u00ae health survey update, 2014 www.sf-36.org\/tools\/sf36.shtml"},{"issue":"3","key":"10.1002\/14651858.CD011644.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s15010-004-3062-8","article-title":"Natural history of acute symptomatic hepatitis type C","volume":"32","author":"Wawrzynowicz-Syczewska","year":"2004","journal-title":"Infection"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011644.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gutjnl-2012-302144","article-title":"New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives","volume":"61","author":"Welsch","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD011644.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011644.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jhep.2005.04.007","article-title":"Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study","volume":"43","author":"Wiese","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"7644","key":"10.1002\/14651858.CD011644.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"10","key":"10.1002\/14651858.CD011644.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.puhe.2008.01.014","article-title":"Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis","volume":"122","author":"Xia","year":"2008","journal-title":"Public Health"},{"issue":"9","key":"10.1002\/14651858.CD011644.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12553","article-title":"Liver transplantation: a systematic review of long-term quality of life","volume":"34","author":"Yang","year":"2014","journal-title":"Liver International"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011644.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:58:17Z","timestamp":1628549897000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011644.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,3]]},"references-count":109,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011644.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,3]]}}}